Berrin Yalınbaş Kaya

4PUBLICATIONS
12CO-AUTHORS
Foetal development and medicineBiologically active moleculesCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jul 31, 2026
Low-dose iron therapy during menstruation to prevent recurrence of iron deficiency anaemia: the role of RDW in monitoring.

|Jul 28, 2026
Spinosin Attenuates HCl/Ethanol-Induced Gastric Mucosal Injury by Modulating Oxidative Stress, Inflammation, Apoptosis, and Nrf2/HO-1-Associated Responses.

|Feb 17, 2025
Syringaldehyde Mitigates Cyclophosphamide-Induced Liver and Kidney Toxicity in Mice by Inhibiting Oxidative Stress, Inflammation, and Apoptosis Through Modulation of the Nrf2/HO-1/NFκB Pathway.

Ali Tureyen, Selcan Cesur, Berrin Yalinbas-Kaya

|Jan 08, 2025
Iristectorin A Ameliorates Cisplatin-Induced Hepatorenal Injury in Mice Through Modulation of the Nrf2/HO-1 Signaling Pathway.

Berrin Yalinbas-Kaya, Ali Tureyen, Selcan Cesur

Pageof 1

Frequent Collaborators

1 joint publications

Ali Tureyen

1 joint publications

Selcan Cesur

1 joint publications

Zeynep Irmak Kaya

1 joint publications

Abdülkadir Sağdıç